M Portier
Impact in
- Pharmacology top 1%
- Cannabis and Cannabinoid Research
-
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
Papers in
-
- Multiple Myeloma Research and Treatments 6
-
- Signaling Pathways in Disease 1
- Co-authors
- Pierre Casellas (4 shared papers)Francis Barth (2 shared papers)Bernard Calandra (2 shared papers)M Rinaldi-Carmona (2 shared papers)Régis Bataille (4 shared papers)Gérard Le Fur (1 shared paper)David Shire (1 shared paper)Christian Congy (1 shared paper)
In The Last Decade
M Portier
13 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Pharmacology 655
- Cellular and Molecular Neuroscience 449
- Hematology 268
- Toxicology 74
- Endocrine and Autonomic Systems 130
Countries citing papers authored by M Portier
This map shows the geographic impact of M Portier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Portier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Portier more than expected).
Fields of papers citing papers by M Portier
This network shows the impact of papers produced by M Portier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Portier. The network helps show where M Portier may publish in the future.
Co-authors
The 25 scholars most cited alongside M Portier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor Hit paper breakdown → | 1998 | 593 |
| 2 | 1996 | 158 | |
| 3 | p53 and RAS gene mutations in multiple myeloma. | 1992 | 120 |
| 4 | Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma. | 1991 | 109 |
| 5 | 1999 | 89 | |
| 6 | 1991 | 86 | |
| 7 | 1993 | 69 | |
| 8 | 2001 | 47 | |
| 9 | 1990 | 29 | |
| 10 | 1998 | 5 | |
| 11 | 2024 | 3 | |
| 12 | 1993 | 3 | |
| 13 | 2025 | 1 |
About M Portier
M Portier is a scholar working on Hematology, Molecular Biology, Cellular and Molecular Neuroscience, Oncology and Surgery, having authored 13 papers that have together received 1.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (6 papers), Chemokine receptors and signaling (2 papers), Blood donation and transfusion practices (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Cannabis and Cannabinoid Research (2 papers), Neurotransmitter Receptor Influence on Behavior (2 papers), Pancreatic function and diabetes (1 paper) and Signaling Pathways in Disease (1 paper). The work is most often cited by research in Pharmacology (655 citations), Cellular and Molecular Neuroscience (449 citations), Hematology (268 citations), Toxicology (74 citations) and Endocrine and Autonomic Systems (130 citations). M Portier has collaborated with scholars based in France and Australia. Frequent co-authors include Pierre Casellas, Francis Barth, Bernard Calandra, M Rinaldi-Carmona, Régis Bataille, Gérard Le Fur, David Shire, Christian Congy, J. C. Brelière and Monsif Bouaboula. Their work appears in journals such as Blood, Journal of Pharmacology and Experimental Therapeutics, Transfusion, Neuropeptides and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.